Marine Natural Products: A Source of Novel Anticancer Drugs

Funding Number

PR1813SC01

Author's Department

Chemistry Department

Find in your Library

https://pubmed.ncbi.nlm.nih.gov/31443597/

All Authors

Shaden A. M. Khalifa; Nizar Elias; Mohamed A. Farag; Lei Chen; Aamer Saeed; Mohamed-Elamir F. Hegazy; Moustafa S. Moustafa; Aida Abd El-Wahed; Saleh M. Al-Mousawi; Syed G. Musharraf; Fang-Rong Chang; Arihiro Iwasaki; Kiyotake Suenaga; Muaaz Alajlani; Ulf Göransson; Hesham R. El-Seedi

Document Type

Research Article

Publication Title

Marine Drugs

Publication Date

12-31-2019

doi

10.3390/md17090491.

Abstract

Cancer remains one of the most lethal diseases worldwide. There is an urgent need for new drugs with novel modes of action and thus considerable research has been conducted for new anticancer drugs from natural sources, especially plants, microbes and marine organisms. Marine populations represent reservoirs of novel bioactive metabolites with diverse groups of chemical structures. This review highlights the impact of marine organisms, with particular emphasis on marine plants, algae, bacteria, actinomycetes, fungi, sponges and soft corals. Anti-cancer effects of marine natural products in in vitro and in vivo studies were first introduced; their activity in the prevention of tumor formation and the related compound-induced apoptosis and cytotoxicities were tackled. The possible molecular mechanisms behind the biological effects are also presented. The review highlights the diversity of marine organisms, novel chemical structures, and chemical property space. Finally, therapeutic strategies and the present use of marine-derived components, its future direction and limitations are discussed.

First Page

491

Last Page

491

This document is currently not available here.

Find this item online

Share

COinS